USSTOCK.TODAY
Market Closed
Log in Sign up

BioHarvest Sciences Shifts to Profitability-Focused Strategy and Announces Q3 Results

The Motley Fool +1 · ·by G4L

BHST
BHST BioHarvest Sciences Inc
$1.63 -6.86%
View chart & analysis →
  1. 1BioHarvest Sciences recorded revenue of $7.9 million in Q3 2026.
  2. 2BioHarvest Sciences recorded a net loss of $3.3 million in Q3 2026.
  3. 3CEO Zaki Rakib plans to limit capital expenditures to under $5 million in 2027.

So what's the key point?

BioHarvest Sciences generated $7.9 million in revenue in Q3 2026 but saw a loss of $3.3 million. The company plans to limit capital expenditures to under $5 million in 2027.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

BioHarvest Sciences Inc Announces Q3 2026 Results and Strategic Priorities Newsfile Corp. +1 · 13h agoBioHarvest Sciences Announces Commercial Readiness of Olive Cell Composition Newsfile Corp. +1 · Oct 13BioHaven (BHST) Pursues Dual Listing on Tel Aviv Stock Exchange Newsfile Corp. +2 · Sep 3
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news